LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids
News - Moves strengthen existing analytical and bioanalytical drug development service offering
03 April 2017
LGC expands Fordham site to bolster Bioanalytical and CMC capacity
News - LGC is expanding its Bioanalytical and CMC analytical services capacity at its site in Fordham, Cambridgeshire.
23 November 2017